Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study.
作者信息
Greenberg A J, Philip S, Paner A, Velinova S, Badros A, Catchatourian R, Ketterling R, Kyle R A, Kumar S, Vachon C M, Rajkumar S V
出版信息
Blood Cancer J. 2015 Feb 13;5(2):e279. doi: 10.1038/bcj.2015.8.
Abstract
摘要
相似文献
1
Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study.
Blood Cancer J. 2015 Feb 13;5(2):e279. doi: 10.1038/bcj.2015.8.
2
[A modified cytogenetic study for multiple myeloma].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Apr;23(2):213-5.
3
[The significance and current diagnostic options of cytogenetic changes in multiple myeloma].
Vnitr Lek. 2006 Nov;52 Suppl 2:76-8.
4
Cytogenetic and molecular aberrations of multiple myeloma patients: a single-center study in Singapore.
Chin Med J (Engl). 2013;126(10):1872-7.
5
[Multiple myeloma: etiology, epidemiology, tumor biology and pathophysiology].
Nihon Rinsho. 1995 Mar;53(3):543-51.
6
[Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study].
Korean J Lab Med. 2008 Dec;28(6):413-8. doi: 10.3343/kjlm.2008.28.6.413.
7
[Magnetic-activated cell sorting combined with multiplex ligation-dependent probe amplification for detecting molecular cytogenetic abnormalities in multiple myeloma].
Nan Fang Yi Ke Da Xue Xue Bao. 2012 Sep;32(9):1332-5.
8
9
[The cytogenetic and molecular genetic study of 81 multiple myeloma patients].
Zhonghua Nei Ke Za Zhi. 2011 Dec;50(12):1039-42.
10
Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients.
Am J Hematol. 2012 Sep;87(9):861-4. doi: 10.1002/ajh.23258. Epub 2012 May 28.
引用本文的文献
1
Addressing the disparities: the approach to the African American patient with multiple myeloma.
Blood Cancer J. 2023 Dec 18;13(1):189. doi: 10.1038/s41408-023-00961-0.
2
Cytogenetic Abnormalities in Multiple Myeloma: Incidence, Prognostic Significance, and Geographic Heterogeneity in Indian and Western Populations.
Cytogenet Genome Res. 2022;162(10):529-540. doi: 10.1159/000529191. Epub 2023 Feb 13.
3
Socioeconomic disadvantage contributes to ethnic disparities in multiple myeloma survival: a matched cohort study.
Blood Cancer J. 2022 May 25;12(5):82. doi: 10.1038/s41408-022-00681-x.
4
Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study.
Blood Cancer J. 2022 Feb 24;12(2):34. doi: 10.1038/s41408-022-00633-5.
5
Towards a unified approach for multiple myeloma care in Kenya - proceedings of the Inaugural Multiple Myeloma Congress.
Pan Afr Med J. 2021 Dec 17;40:236. doi: 10.11604/pamj.2021.40.236.30742. eCollection 2021.
6
[Epidemiological analysis of cytogenetic abnormalities in patients with newly-diagnosed multiple myeloma: a multi-center retrospective study].
Zhonghua Xue Ye Xue Za Zhi. 2020 Jan 14;41(1):10-15. doi: 10.3760/cma.j.issn.0253-2727.2020.01.003.
7
Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma.
J Clin Oncol. 2019 Jul 1;37(19):1657-1665. doi: 10.1200/JCO.18.00776. Epub 2019 May 15.
8
Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry.
Blood Cancer J. 2018 Oct 10;8(10):96. doi: 10.1038/s41408-018-0132-1.
9
Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India.
Indian J Med Res. 2016 Oct;144(4):536-543. doi: 10.4103/0971-5916.200890.
10
Prevalence, incidence and survival of smoldering multiple myeloma in the United States.
Blood Cancer J. 2016 Oct 21;6(10):e486. doi: 10.1038/bcj.2016.100.
Zotero 插件